750 results on '"Skowasch, Dirk"'
Search Results
2. Autorinnen und Autoren
3. Relevance of serum levels of the endoplasmic reticulum stress protein GRP78 (glucose-regulated protein 78 kDa) as biomarker in pulmonary diseases
4. Dupilumab bei chronisch-obstruktiver Lungenerkrankung
5. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
6. Cardiac autonomic dysfunction in adult congenital heart disease
7. Relevance of serum levels of the endoplasmic reticulum stress protein GRP78 (glucose-regulated protein 78 kDa) as biomarker in pulmonary diseases
8. Prevalence of sleep-disordered breathing in patients with mitral regurgitation and the effect of mitral valve repair
9. ER-stress-induced secretion of circulating glucose-regulated protein 78kDa (GRP78) ameliorates pulmonary artery smooth muscle cell remodelling
10. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
11. Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany
12. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
13. Characterization of Obesity in Severe Asthma in the German Asthma Net
14. Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry
15. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry
16. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
17. German asthma net: Nasal polyposis in patients in the severe asthma registry
18. Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease
19. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
20. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
21. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
22. Aktuelle Entwicklungen in der Schlafforschung und Schlafmedizin – eine Einschätzung der AG „Herz- und Kreislauferkrankungen“
23. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells
24. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort
25. Sarkoidose – Mechanismen und Bildgebung
26. Allergische bronchopulmonale Aspergillose (ABPA) – ein Update
27. Impact of interstitial lung disease on left ventricular myocardial function
28. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
29. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
30. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
31. Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension (IPAH) patients with comorbidities
32. Early-stage idiopathic pulmonary fibrosis is characterized by bronchoalveolar accumulation of SPP1+macrophages
33. Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?
34. Pulmonale Hypertonie assoziiert mit Lungenerkrankungen
35. Diagnostik und Therapie der pulmonalarteriellen Hypertonie
36. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
37. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
38. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
39. Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP).
40. No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in Germany
41. Bronchial Rheoplasty for Chronic Bronchitis: 6-Month Results from the European Registry Study
42. Initiation, response assessment and switch of antibody therapies in patients with severe asthma – a survey among German specialists
43. Response to biologics and clinical remission in the adult GAN severe asthma cohort.
44. German Asthma Net: Nasal polyposis in patients with severe asthma
45. Impact of smoking on biologicals treatment response in patients from the German Severe Asthma (GAN) Registry
46. Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany
47. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients
48. Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension patients with comorbidities.
49. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: A COMPERA analysis
50. Preclinical atherosclerotic burden in carotid and lower extremity arteries in adults with congenital heart disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.